Inventorship: Be Ever Aware of Who Owns What

Inventorship remains the touchstone of who owns patentable technology.  Yet inventorship remains, at times, one of the most perplexing and contentious aspects of patent law. Case in point is the recent 111-page decision in Dana-Faber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd., et. al, Case No. 15-13443, by Judge Saris in the United States … Continue reading Inventorship: Be Ever Aware of Who Owns What

Reasonable Expectations of Success and Compound Claims “As a Whole”

Challenges to new molecule patents frequently hinge on the question of obviousness in view of a prior art “lead compound.” More often than not, patentees fend off these challenges by successfully arguing against selection or modification of the asserted lead compound, and/or by showing unexpected properties. But when the skilled person had at least some reason … Continue reading Reasonable Expectations of Success and Compound Claims “As a Whole”